By Aditi Shah NEW DELHI (Reuters) – India’s EV policy, which offers import tax cuts for foreign automakers investing in the country, will restrict them from using funds spent on charging infrastructure for such relief, increasing their car manufacturing, a government document shows. India last year announced a policy aimed at attracting Tesla to manufacture …
(Reuters) -Indian food and grocery delivery firm Swiggy said on Friday it will invest up to 10 billion rupees ($115.47 million) in its supply chain subsidiary, amid an ongoing expansion of its fast-growing quick-commerce arm Instamart. Scootsy provides services such as warehouse management and processing to improve order deliveries and shipping processes for wholesalers and …
India’s Swiggy to invest $115 million in supply chain unit amid quick-commerce expansion Read More »
By Dharamraj Dhutia MUMBAI (Reuters) – The Reserve Bank of India will conduct a massive $10 billion three-year dollar/rupee swap auction next week to infuse durable rupee liquidity into the banking system, which has been reeling under large cash deficits, the central bank said on Friday. The RBI will conduct the buy/sell swap on February …
India’s RBI announces mega $10 billion FX swap to infuse rupee liquidity Read More »
By Swati Bhat MUMBAI (Reuters) – India’s inflation is seen aligning with the target of 4%, which opens up space for monetary policy to address concerns on the growth front, members of the rate-setting committee said in the minutes of the latest meeting released on Friday. Earlier in February, India’s Monetary Policy Committee (MPC) cut …
India’s rate panel shifts focus to growth as inflation seen easing, minutes show Read More »
By Rishika Sadam HYDERABAD (Reuters) – (This Feb.19 story has been corrected to say that generic drugs overall, not just those supplied by Indian drugmakers, resulted in $408 billion in savings for the U.S. healthcare system, in paragraph 4) U.S. President Donald Trump said on Tuesday he intends to impose a “25% or higher” levies …
Indian drugmakers with big US exposure as Trump plans pharmaceutical import tariffs Read More »
(Reuters) – India’s foreign exchange reserves snapped a three-week gaining streak to drop to $635.72 billion as of February 14, coming off over one-month highs, data released by the central bank on Friday showed. The reserves fell by $2.54 billion in the reported week, the most in a month. The reserves had risen by a …
India’s forex reserves snap 3-week gaining streak Read More »
By Dharamraj Dhutia MUMBAI (Reuters) – India’s central bank will need to inject at least another 1 trillion rupees ($11.54 billion) into the banking system by March-end as durable liquidity remains in a deficit despite a recent cash infusion, market participants said on Friday. “The need for durable liquidity infusion till March 2025 is estimated …
By Rishika Sadam HYDERABAD, India (Reuters) – Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even if President Donald Trump imposes high tariffs because they are “highly competitive”, a government-backed trade body said. The U.S. accounts for nearly a third of India’s pharmaceutical exports, …
Indian drugmakers can retain US dominance even with tariffs, says industry body Read More »
Feb 21 (Reuters) – The Indian government had no outstanding loans with the central bank under ways and means advances in the week ended Feb. 14, according to the Reserve Bank of India’s weekly statistical supplement released on Friday. The central government had no outstanding loans in the week earlier as well. State governments had …
Indian govt had no outstanding loans from RBI in Feb 14 week Read More »
(Reuters) – India’s Niva Bupa Health Insurance Co said on Friday it is investigating claims of customer data leaks after receiving an email from an anonymous source. (Reporting by Aleef Jahan in Bengaluru; Editing by Savio D’Souza)
